Synapse

← Annual Review of Cancer Biology

Papers in Annual Review of Cancer Biology

Page 1 · newest first

  1. The Watchful Many: Platelets at the Intersection of Hemostasis, Immunity, and CancerAnnual Review of Cancer Biology · 2026
  2. Aging Stem Cells and Somatic Mosaicism as a Precursor to Malignant TransformationAnnual Review of Cancer Biology · 2026
  3. How Tumor Cells Colonize the Most Protected OrgansAnnual Review of Cancer Biology · 2026
  4. Unmasking Cellular Plasticity from Development to Cancer by Lineage TracingAnnual Review of Cancer Biology · 2026
  5. Fluxes and Functions of the Sphingolipid Cycle Within the Tumor MicroenvironmentAnnual Review of Cancer Biology · 2026
  6. Cohesin Mutations in Cancer and DevelopmentAnnual Review of Cancer Biology · 2026
  7. Engineering the Allogeneic Stem Cell Graft for AML Immunotherapy: From Transplant Protection to Therapeutic RedistributionAnnual Review of Cancer Biology · 2026
  8. Promoting Toxic Metabolites in Cancer TherapyAnnual Review of Cancer Biology · 2026
  9. Cancer Predisposition in Li-Fraumeni SyndromeAnnual Review of Cancer Biology · 2026
  10. Designing the Perfect Strike Against Cancer: Clocking In with the Circadian RhythmAnnual Review of Cancer Biology · 2026
  11. The Angiocrine Niche in Cancer Therapy Responses: The Role of Vascular Endothelial Cells in ImmunomodulationAnnual Review of Cancer Biology · 2026
  12. Evolution of Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1: Opportunities for Prevention and Therapeutic StrategiesAnnual Review of Cancer Biology · 2026
  13. Molecular Pathogenesis and Therapeutic Response of Diffuse Large B Cell Lymphoma Genetic SubtypesAnnual Review of Cancer Biology · 2026
  14. Cancer Cell Polarity and ExtrusionAnnual Review of Cancer Biology · 2026
  15. Transcriptional and Epigenetic Regulation of T Cell States in CancerAnnual Review of Cancer Biology · 2026
  16. Cancer Dormancy as a Collective Phenomenon Across Scales in Length and Time: Biological Observations and Advanced 3D Bioengineered ModelsAnnual Review of Cancer Biology · 2025
  17. TRACERx as an Optimized Paradigm for Understanding Cancer EvolutionAnnual Review of Cancer Biology · 2025
  18. Antibody–Drug Conjugates: The Past, Present and FutureAnnual Review of Cancer Biology · 2025
  19. Antibody–Drug Conjugates: The Past, Present and FutureAnnual Review of Cancer Biology · 2025
  20. lncRNAs as Targetable Nodes of Oncogenic Networks Underlying Cancer Progression and Therapy ResistanceAnnual Review of Cancer Biology · 2025
  21. Targeting RAS for Cancer Treatment: What a Long, Strange Trip It's BeenAnnual Review of Cancer Biology · 2025
  22. Lessons from 3D Reconstruction of CancerAnnual Review of Cancer Biology · 2025
  23. Lessons from 3D Reconstruction of CancerAnnual Review of Cancer Biology · 2025
  24. Targeting RAS for Cancer Treatment: What a Long, Strange Trip It's BeenAnnual Review of Cancer Biology · 2025
  25. lncRNAs as Targetable Nodes of Oncogenic Networks Underlying Cancer Progression and Therapy ResistanceAnnual Review of Cancer Biology · 2025
  26. The Evolution of Radioligand Therapy: Next-Generation Strategies to Expand the Therapeutic WindowAnnual Review of Cancer Biology · 2025
  27. Mitochondria, OXPHOS, and Cancer Progression: A Modular ViewAnnual Review of Cancer Biology · 2025
  28. Age-Related Metabolic Reprogramming in Cancer Cell PlasticityAnnual Review of Cancer Biology · 2025
  29. Beyond Mice and Men: Alternative Vertebrate and Invertebrate Models in Cancer BiologyAnnual Review of Cancer Biology · 2025
  30. Engineering Cancer with Next-Generation Genome Editing ToolsAnnual Review of Cancer Biology · 2025
  31. Glycosylation in Cancer: From Functional Roles to Therapeutic ImplicationsAnnual Review of Cancer Biology · 2025
  32. Metabolic Reprogramming in Cancer CachexiaAnnual Review of Cancer Biology · 2025
  33. Natural and Engineered Cytokines as Cancer TherapeuticsAnnual Review of Cancer Biology · 2025
  34. Impact of Chromosomal Instability and Aneuploidy in Cancer DevelopmentAnnual Review of Cancer Biology · 2025
  35. They Contain Multitudes: The Diverse Roles of CD4+ T Cells in Cancer ImmunityAnnual Review of Cancer Biology · 2025
  36. Cancer Dependency Map: Past and PresentAnnual Review of Cancer Biology · 2025
  37. Preclinical Models of Solid Cancers for Testing Cancer ImmunotherapiesAnnual Review of Cancer Biology · 2025
  38. Road Map to Defeat Pancreatic CancerAnnual Review of Cancer Biology · 2025
  39. Emerging Mechanisms of Lactate Regulation of Biological ProcessesAnnual Review of Cancer Biology · 2025
  40. Insights into Leukemia from Single-Cell GenomicsAnnual Review of Cancer Biology · 2024
  41. Navigating Nongenetic Plasticity in Cancer Drug ResistanceAnnual Review of Cancer Biology · 2024
  42. Mechanism of Action of PARP InhibitorsAnnual Review of Cancer Biology · 2024
  43. Targeting Minimal Residual DiseaseAnnual Review of Cancer Biology · 2024
  44. Single-Cell Technologies for Studying the Evolution and Function of Mitochondrial DNA Heteroplasmy in CancerAnnual Review of Cancer Biology · 2024
  45. Awakening the Genome: CRISPR Activation to Unravel the Origin and Vulnerabilities of CancerAnnual Review of Cancer Biology · 2024
  46. The Role of B Cells in Solid TumorsAnnual Review of Cancer Biology · 2024
  47. Not All Carcinogens Are Directly Mutagenic: A Holistic View of the Environmental Exposure–Cancer ConnectionAnnual Review of Cancer Biology · 2024
  48. Lineage-Specific Transcription Factors in CarcinogenesisAnnual Review of Cancer Biology · 2024
  49. Development of PROTAC Degrader Drugs for CancerAnnual Review of Cancer Biology · 2024
  50. Genetic and Epigenetic Dysregulation of Transcriptional Enhancers in CancerAnnual Review of Cancer Biology · 2024